SLC12A5 and epilepsy: The strongest genetic evidence for KCC2 dysfunction in epilepsy is demonstrated by studies of patients in families with a severe infantile epilepsy syndrome termed epilepsy of infancy with migrating focal seizures (EIMFS; Stödberg et al., 2015; Saitsu et al., 2016; Saito et al., 2017).